Gore Marks Two-Year Primary Endpoint Follow-up Milestone in Study of GORE® CARDIOFORM Septal Occluder for Patent Foramen Ovale (PFO) Closure
Completion of follow -up paves way for REDUCE Clinical Study data submission to FDA for PFO indication
Gore Presents Astronaut and Scientist Mae C. Jemison, MD, as Keynote Speaker at Women in Vascular Leadership Luncheon
The pioneering Dr. Jemison, who flew aboard the Space Shuttle Endeavour, will address vascular surgeons at the 2014 SCVS symposium in Carlsbad, Calif.
Market-leading TEVAR Device is First to Surpass 100,000 Devices Distributed Worldwide
Proven, durable device leads the market, continues to impact lives
Study Confirms GORE® BIO-A® Tissue Reinforcement a Proven Alternative to Biologics in Hernia Repair
Two-year study demonstrates improved patient satisfaction with Gore material
Nominees Announced for 2016 Pioneers in Performance Awards for North America; Online Voting Opens at www.PioneersInPerformance.com
Awards program honors medical specialists advancing therapy and improving patient and clinical performance through active collaboration
Gore Launches Early Cannulation Capable GORE® ACUSEAL Vascular Graft
Results of early cannulation clinical trial presented at the 2013 VEITHsymposium
Gore Again Named One of the 100 Best Companies to Work For®
Every year since 1998: That’s how long W. L. Gore & Associates has appeared on the Fortune 100 Best Companies to Work For® list
GORE® EXCLUDER® Iliac Branch Endoprosthesis is First Dedicated System of Its Kind Registered in Australia and New Zealand
First Successful Implants Providing Endovascular Repair to Iliac Arteries Completed in Australia
GORE® EXCLUDER® Iliac Branch Endoprosthesis Gains FDA Approval
Gore designed all-in-one system to preserve iliac artery blood flow in patients with iliac or aortoiliac aneurysms
First Implant Completed in Thoracoabdominal Aortic Aneurysm Clinical Study
New investigative Gore device is designed to treat aortic aneurysms involving visceral branch vessels